MyPEEPS Mobile Plus

About the Study

MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in young men who have sex with men (YMSM, n=500), is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on our strong preliminary work, the proposed research is designed to assess whether refinement of this mobile intervention used in combination with virtual PrEP Peer Navigation will result in improvements in PrEP uptake and a reduction in HIV-related behavior. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.

The study is led by Columbia University School of Nursing and Lurie Children’s Hospital of Chicago. All participants will complete surveys at baseline, 3-, 6-, and 12-month time-points. Participants will be randomized into two groups: both groups will receive standard of care information about PrEP and access to the MyPEEPS Mobile App for the entire 12-month duration of the study, and the intervention group will also receive access to PrEP peer navigation, where PrEP peer navigators will link participants to PrEP care, monitor uptake, and persistence.

For Participants

• The MyPEEPS Mobile for Young Trans Men study is a 12-month study looking at a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to young transgender youth.
• Inclusion Criteria:
  • Aged 17 to 25 years.
  • Assigned male sex at birth;
  • Identify as male, non-binary, or genderqueer;
  • Understand and read English;
  • Live within one of the Ending the HIV Epidemic areas in the US;
  • Own a smartphone;
  • Self-report condomless receptive anal sex with a male in the past year; and
  • HIV-negative (OraQuick verified)
• Exclusion Criteria:
  • HIV positive;
  • Unable to provide informed consent due to severe mental or physical illness or substance intoxication at the time of enrollment;
  • Concurrently enrolled in another HIV prevention study.
• Screening for this study has not yet begun
• Resources or FAQ list, detailing participant profile: